Wesbanco Bank Inc Abbott Laboratories Transaction History

Wesbanco Bank Inc

$2.89 Billion
Q3 2024

A detailed history of Wesbanco Bank Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Wesbanco Bank Inc holds 107,066 shares of ABT stock, worth $12.3 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

107,066

Previous 123,124 13.04%

Holding current value

$12.3 Million

Previous $12.8 Million 4.59%

% of portfolio

0.42%

Previous 0.48%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$100.07 - $118.13 $1.61 Million - $1.9 Million	-16,058 Reduced 13.04%	107,066 $12.2 Million
Q2 2024 Jul 11, 2024	SELL	$100.73 - $112.44 $38,680 - $43,176	-384 Reduced 0.31%	123,124 $12.8 Million
Q1 2024 Apr 23, 2024	BUY	$109.52 - $120.96 $8.68 Million - $9.59 Million	79,245 Added 179.03%	123,508 $14 Million
Q4 2023 Feb 16, 2024	SELL	$90.19 - $110.4 $7.18 Million - $8.79 Million	-79,614 Reduced 64.27%	44,263 $4.87 Million
Q3 2023 Dec 11, 2023	SELL	$95.53 - $114.62 $81,582 - $97,885	-854 Reduced 0.68%	123,877 $12 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $50,793 - $56,594	-504 Reduced 0.4%	124,731 $13.6 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $25,764 - $30,326	-266 Reduced 0.21%	125,235 $12.7 Million
Q4 2022 Jan 18, 2023	BUY	$95.06 - $111.52 $7.74 Million - $9.08 Million	81,424 Added 184.73%	125,501 $13.8 Million
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $9.16 Million - $10.6 Million	-94,656 Reduced 68.23%	44,077 $4.26 Million
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $231,392 - $279,679	-2,267 Reduced 1.61%	138,733 $15.1 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $422,900 - $515,699	-3,709 Reduced 2.56%	141,000 $16.7 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $70,473 - $86,290	-610 Reduced 0.42%	144,709 $20.4 Million
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $25,665 - $28,393	220 Added 0.15%	145,319 $17.2 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $916,247 - $1.08 Million	8,661 Added 6.35%	145,099 $16.8 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $77,602 - $91,427	-713 Reduced 0.52%	136,438 $16.4 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $933,170 - $1.13 Million	-10,183 Reduced 6.91%	137,151 $14.9 Million
Q2 2020 Jul 14, 2020	SELL	$76.57 - $98.0 $137,749 - $176,302	-1,799 Reduced 1.21%	147,334 $13.5 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $1.91 Million - $2.79 Million	-30,415 Reduced 16.94%	149,133 $11.8 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 0.06%	179,548 $15.6 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $105,491 - $114,385	-1,289 Reduced 0.71%	179,648 $15 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $30,682 - $35,785	-421 Reduced 0.23%	180,937 $15.2 Million
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $1.21 Million - $1.46 Million	18,205 Added 11.16%	181,358 $14.5 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $81,294 - $92,094	-1,240 Reduced 0.75%	163,153 $11.8 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $17,938 - $21,641	-295 Reduced 0.18%	164,393 $12.1 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $122,451 - $135,149	2,127 Added 1.31%	164,688 $10 Million
Q1 2018 May 18, 2018	BUY	$56.27 - $63.62 $6.11 Million - $6.91 Million	108,646 Added 201.51%	162,561 $9.74 Million
Q4 2017 Feb 01, 2018	SELL	$53.68 - $57.47 $6 Million - $6.42 Million	-111,775 Reduced 67.46%	53,915 $3.08 Million
Q3 2017 Nov 02, 2017	SELL	$48.06 - $53.64 $31,239 - $34,866	-650 Reduced 0.39%	165,690 $8.84 Million
Q2 2017 Aug 08, 2017	BUY	N/A	166,340	166,340 $8.09 Million

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Abbott Laboratories Transaction History